Quarterly Activities Report & Appendix 4C
Filed with ASX · · 9 pages · English
Summary by 6ix AI
The report highlights the development of a silicon chip for blood testing and the establishment of a new advisory committee to enhance technological commercialization efforts. Financially, the company reported a strong cash position with no debt, supporting ongoing research and development activities.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Archer Materials Limited on 6ix
Story so far
Earlier from Archer Materials
- TMR Sensor Functionality at Cryogenic Temperature
- Archer Advances Quantum Technology
- Biochip integrates with readout circuitry on a silicon chip
- Archer partners with Paragraf for Biochip development
- Quarterly Activity Report & Appendix 4C
Later from Archer Materials
- AXE to Unlock Scalable Potassium Sensor Production with IMEC
- FY25 Results and Appendix 4E
- AXE builds on EDMR breakthrough to advance qubit development
- Archer and Emergence partner to pursue graphene quantum tech
- Silicon Biochip meets performance and clinical requirements
Follow Archer Materials into a list and get an email when it puts out news.
Follow Archer Materials